Endocrine aspects of management of patients with vaginal infections

1. Schooley R.T. The human microbiome: implications for health and disease, including HIV infection. Top. Antivir. Med. 2018; 26(3): 75-78.
2. Smith S.B., Ravel J. The vaginal microbiota, host defence and reproductive physiology. J. Physiol. 2017; 595(2): 451-63.
3. Wagner R.D., Johnson S.J. Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J. Biomed. Sci. 2012; 19: 58.
4. Wira C.R., Rodriguez-Garcia M., Patel M.V. The role of sex hormones in immune protection of the female reproductive tract. Nat. Rev. Immunol. 2015; 15(4): 217-30. https://dx.doi.org/10.1038/nri3819.
5. Borgdorff H., Armstrong S.D., Tytgat H.L., Xia D., Ndayisaba G.F., Wastling J.M., van de Wijgert J.H. Unique insights in the cervicovaginal Lactobacillus iners and L. crispatus proteomes and their associations with microbiota dysbiosis. PLoS One. 2016; 11(3): e0150767. https://dx.doi.org/10.1371/journal.pone.0150767.
6. Witkin S., Linhares I. Why do lactobacilli dominate the human vaginal microbiota? BJOG. 2016; 124(4): 606-11. https://dx.doi.org/10.1111/1471-0528.14390.
7. Bautista C.T., Wurapa E., Sateren W.B., Morris S., Hollingsworth B., Sanchez J.L. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil. Med. Res. 2016; 3: 4.
8. Малова И.О., Афанасьева И.Г. Бактериальный вагиноз: есть ли альтернатива традиционным препаратам? Медицинский совет. 2019; 7: 34-44. [Malova I.O., Afanasyeva I.G. Bacterial vaginosis: is there an alternative to traditional drugs? Medical advice. 2019; 7: 34-44. (in Russian)].
9. Vodstrcil L.A., Hocking J.S., Law M., Walker S., Tabrizi S.N., Fairley C.K. et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One. 2013; 8(9): e73055. https://dx.doi.org/10.1371/journal.pone.0073055.
10. Špaček J., Kestřánek J., Jílek P., Leško D., Plucnarová S., Buchta V. Comparison of two long-term gestagen regimens in the management of recurrent vulvovaginal candidiasis: A pilot study. Mycoses. 2017; 60(4): 260-5. https://dx.doi.org/10.1111/myc.12593.
11. Li D., Wang T., Shen S., Fang Z., Dong Y., Tang H. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. Diabetes Obes. Metab. 2017; 19(3): 348-55.
12. Liu J., Li L., Li S., Jia P., Deng K., Chen W., Sun X. Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis. Sci. Rep. 2017; 7(1): 2824. https://dx.doi.org/10.1038/s41598-017-02733-w.
13. Dave C.V., Schneeweiss S., Patorno E. Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors. Diabetes Obes. Metab. 2019; 21(2): 434-8. https://dx.doi.org/10.1111/dom.13531.
14. Sacks D.A., Black M.H., Li X., Montoro M.N., Lawrence J.M. Adverse pregnancy outcomes using the international association of the diabetes and pregnancy study groups criteria: glycemic thresholds and associated risks. Obstet. Gynecol. 2015; 126(1): 67-73.
15. Zhang X., Liao Q., Wang F., Li D. Association of gestational diabetes mellitus and abnormal vaginal flora with adverse pregnancy outcomes. Medicine (Baltimore). 2018; 97(34): e11891. https://dx.doi.org/10.1097/MD.0000000000011891.
16. Seo D., Rabinowitz A.G., Douglas R.J., Sinha R. Limbic response to stress linking life trauma and hypothalamus-pituitary-adrenal axis function. Psychoneuroendocrinology. 2019; 99: 38-46. https://dx.doi.org/10.1016/j.psyneuen.2018.08.023.
17. Amabebe E., Anumba D.O.C. The vaginal microenvironment: the physiologic role of Lactobacilli. Front. Med. (Lausanne). 2018; 5: 181. https://dx.doi.org/10.3389/fmed.2018.00181.
18. Amabebe E., Anumba D.O.C. Psychosocial stress, cortisol levels, and maintenance of vaginal health. Front. Endocrinol. (Lausanne). 2018; 9: 568. https://dx.doi.org/10.3389/fendo.2018.00568.
19. Ventolini G., Khandelwal N., Hutton K., Lugo J., Gygax S.E. et al. Obesity and recurrent vulvovaginal bacterial infections in women of reproductive age. Postgrad. Med. J. 2017; 93(1099): 297. https://dx.doi.org/10.1136/postgradmedj-2016-134638.
20. Oh H.Y., Seo S.S., Kong J.S., Lee J.K., Kim M.K. Association between obesity and cervical microflora dominated by Lactobacillus iners in Korean women. J. Clin. Microbiol. 2015; 53(10): 3304-9. https://dx.doi.org/10.1128/JCM.01387-15.
21. Sherrard J., Wilson J., Donders G., Mendling W., Jensen J.S. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS. 2018; 29(13): 1258-72. https://dx.doi.org/10.1177/0956462418785451.
22. Российское общество дерматовенерологов и косметологов, Российское общество акушеров-гинекологов. Федеральные клинические рекомендации по ведению больных бактериальным вагинозом. Акушерство и гинекология. 2016; Приложение № 4: 42-8. [Russian Society of Dermatovenerologists and Cosmetologists, Russian Society of Obstetricians and Gynecologists. Federal clinical guidelines for the management of patients with bacterial vaginosis. Obstetrics and gynecology. 2016; Appendix No. 4: 42-8. (in Russian)].
23. Lamont R.F., Nhan-Chang C.L., Sobel J.D., Workowski K., Conde-Agudelo A., Romero R. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am. J. Obstet. Gynecol. 2011; 205(3): 177-90. https://dx.doi.org/10.1016/j.ajog.2011.03.047.
24. Gaspar C., Donders G.G., Palmeira-de-Oliveira R., Queiroz J.A., Tomaz C., Martinez-de-Oliveira J., Palmeira-de-Oliveira A. Bacteriocin production of the probiotic Lactobacillus acidophilus KS400. AMB Express. 2018; 8(1): 153. https://dx.doi.org/10.1186/s13568-018-0679-z.

Received 11.03.2019

Accepted 22.03.2019